CN1108456A - 苯并噻唑化合物及其制法和用途 - Google Patents

苯并噻唑化合物及其制法和用途 Download PDF

Info

Publication number
CN1108456A
CN1108456A CN94190237A CN94190237A CN1108456A CN 1108456 A CN1108456 A CN 1108456A CN 94190237 A CN94190237 A CN 94190237A CN 94190237 A CN94190237 A CN 94190237A CN 1108456 A CN1108456 A CN 1108456A
Authority
CN
China
Prior art keywords
methyl
succinamic acid
difluorobenzothiazol
compound
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94190237A
Other languages
English (en)
Chinese (zh)
Inventor
长谷岳真
云中恭裕
清水千贺子
细野博士
青知士
中村义幸
松井哲夫
石川弘伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ryokugugi K K
Senju Pharmaceutical Co Ltd
Original Assignee
Ryokugugi K K
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ryokugugi K K, Senju Pharmaceutical Co Ltd filed Critical Ryokugugi K K
Publication of CN1108456A publication Critical patent/CN1108456A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/25—Aminoacetonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN94190237A 1993-03-26 1994-03-25 苯并噻唑化合物及其制法和用途 Pending CN1108456A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP05090550A JP3126541B2 (ja) 1993-03-26 1993-03-26 ベンゾチアゾール誘導体、その製法及びその用途
JP90550/93 1993-03-26

Publications (1)

Publication Number Publication Date
CN1108456A true CN1108456A (zh) 1995-09-13

Family

ID=14001528

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94190237A Pending CN1108456A (zh) 1993-03-26 1994-03-25 苯并噻唑化合物及其制法和用途

Country Status (12)

Country Link
US (1) US5532257A (enExample)
EP (1) EP0647636B1 (enExample)
JP (1) JP3126541B2 (enExample)
KR (1) KR100299558B1 (enExample)
CN (1) CN1108456A (enExample)
AT (1) ATE181067T1 (enExample)
AU (1) AU676894B2 (enExample)
CA (1) CA2136743A1 (enExample)
DE (1) DE69418961T2 (enExample)
ES (1) ES2132394T3 (enExample)
TW (1) TW245717B (enExample)
WO (1) WO1994022845A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166084A (zh) * 2018-09-25 2021-07-23 安塔比奥公司 用于治疗细菌感染的茚满衍生物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05337783A (ja) * 1992-06-08 1993-12-21 Ona Electro Erosion Sa 荷積み荷下ろしパレットのドアの自動開放装置
JPH0782259A (ja) * 1993-09-14 1995-03-28 Senju Pharmaceut Co Ltd スクシンアミド酸誘導体及びそれを含有する糖尿病合併症治療剤
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
UA100527C2 (en) * 2007-10-10 2013-01-10 Астразенека Аб Benzothiazoles as ghrelin receptor modulators
AU2020222881B2 (en) 2019-02-13 2025-07-10 Ptc Therapeutics, Inc. Thioeno(3,2-b) pyridin-7-amine compounds for treating familial dysautonomia
US12398140B2 (en) 2019-02-13 2025-08-26 Ptc Therapeutics, Inc. Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia
WO2024003408A1 (en) * 2022-07-01 2024-01-04 Universität Zürich Small-molecule inhibitors of the frs2-fgfr interaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794485A (en) * 1972-06-09 1974-02-26 Polaroid Corp Color diffusion transfer film with incorporated dye and desensitizing agent precursor
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
AU602641B2 (en) * 1986-04-17 1990-10-18 Senju Pharmaceutical Co., Ltd. Thiolactam-N-acetic acid derivatives, their production and use
JPH03107970A (ja) * 1989-09-22 1991-05-08 Ricoh Co Ltd 湿式現像の画像形成装置

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166084A (zh) * 2018-09-25 2021-07-23 安塔比奥公司 用于治疗细菌感染的茚满衍生物
CN113166084B (zh) * 2018-09-25 2024-06-04 安塔比奥公司 用于治疗细菌感染的茚满衍生物

Also Published As

Publication number Publication date
AU6291494A (en) 1994-10-24
CA2136743A1 (en) 1994-10-13
EP0647636A4 (enExample) 1995-04-19
ES2132394T3 (es) 1999-08-16
EP0647636A1 (en) 1995-04-12
US5532257A (en) 1996-07-02
KR950701627A (ko) 1995-04-28
JP3126541B2 (ja) 2001-01-22
ATE181067T1 (de) 1999-06-15
DE69418961D1 (de) 1999-07-15
DE69418961T2 (de) 1999-12-23
JPH06279423A (ja) 1994-10-04
TW245717B (enExample) 1995-04-21
KR100299558B1 (ko) 2001-11-22
AU676894B2 (en) 1997-03-27
EP0647636B1 (en) 1999-06-09
WO1994022845A1 (fr) 1994-10-13

Similar Documents

Publication Publication Date Title
CN1066729C (zh) 苯并咪唑衍生物,其制备方法和其医疗用途
CN1198613C (zh) 氨基苯氧基乙酸衍生物和含有它们的药用组合物
CN1159299C (zh) 芳基烷基哒嗪酮
CN1882555A (zh) 作为免疫抑制剂的5－(苯基－(z)－亚基)－噻唑烷－4－酮衍生物
CN1091006A (zh) 用作降血糖药和治疗早老性痴呆症的化合物
CN1118781A (zh) 具有抗糖尿病活性的杂环化合物及其制备和用途
CN1032751C (zh) 噻唑烷化合物，其制备及其治疗用途
CN1809560A (zh) 作为mtp抑制剂的噻唑基哌啶衍生物
CN1376156A (zh) 苯并二氮杂䓬衍生物、其制备和用途
CN1688557A (zh) 用于治疗神经变性疾病的噻唑化合物
CN1038641A (zh) 取代的4-(喹啉-2-基-甲氧基)苯乙酸衍生物
CN1993346A (zh) 新颖噻吩化合物
CN1615299A (zh) 黄嘌呤氧化酶抑制剂
CN1028521C (zh) 治疗剂
CN1069728A (zh) 美拉德反应抑制剂
CN1155562C (zh) 新的萘化合物、其制备方法及其药物组合物
CN1127252A (zh) 支链氨基被取代的噻唑、其制备方法及含有它们的药物组合物
CN87105501A (zh) 新苯氧基乙酸衍生物及其制备方法和含有它作为活性成分的药物组成
CN1108456A (zh) 苯并噻唑化合物及其制法和用途
CN1254334A (zh) 新颖的对苯二甲酰胺衍生物
CN1071665A (zh) 唑烷酮衍生物
CN1100425A (zh) 噻唑并嘧啶衍生物
CN1590379A (zh) 新的杂环肟化合物、它们的制备方法和含有它们的药物组合物
CN85108115A (zh) 新低血糖剂的制备方法
CN1030451C (zh) 苯并噻唑衍生物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned